Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Intellipharmaceutics International Inc.

http://www.intellipharmaceutics.com/

Latest From Intellipharmaceutics International Inc.

How Two Medtech CEOs Are (And Aren’t) Using ChatGPT In Their Businesses

Two medtech executives talked to Medtech Insight about how they started integrating ChatGPT into their start-ups to help with writing marketing copy, develop websites and presentations, identify KOLs and conferences, and other content.

Artificial Intelligence Business Strategies

Digital Health Roundup: Voice Biomarkers; SXSW, LSI, ACC; FTC BetterHelp Settlement

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses conference highlights from SXSW and LSI while Barnaby Pickering talks about his coverage on voice biomarkers. Hannah Daniel discusses BetterHelp’s return of $7.8m to customers to settle with FTC for sharing health data.

Digital Health Artificial Intelligence

‘Epigenetic Engineering’ Gene Therapy From Epic Bio Shows Early Promise

The San Francisco-based company has taken a step forward with proof of concept for its ‘switch on or switch off’ approach to gene regulation via non-cutting CRISPR molecules.

Neurology Clinical Trials

Finance Watch: VC Mega-Rounds Make A Comeback In March

Private Company Edition: After just seven venture capital rounds of $100m or more in January and February, five have been announced already in March, including a $200m series A round for Cargo Therapeutics, Chroma Medicine’s $135m series B financing and $112m for Noema’s series B.

Financing Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Controlled Release
  • Other Names / Subsidiaries
    • Vasogen, Inc.
UsernamePublicRestriction

Register